Pairing PVC and ACLAR for humidity-sensitive pharmaceutical products
Blister packs remain the workhorse format for solid-dose medicines in Australia, from PBS-listed tablets dispensed through community pharmacies in Sydney and Melbourne to hospital supplies travelling to regional Queensland. The right combination of forming film and lidding stands between an active ingredient and the moisture that can quietly erode its potency before a patient opens the foil. For hygroscopic, efflorescent or water-reactive products, the choice between plain PVC, PVdC-coated PVC and ACLAR laminates is rarely trivial. The challenge grows sharper as the local climate swings between Darwin's wet-season humidity and the dry chill of a Melbourne winter warehouse.
Australian packagers work within a regulatory frame that demands demonstrable stability data. The Therapeutic Goods Administration expects sponsors to back shelf-life claims with real conditioning, and ARTG dossiers routinely include foil characterisation alongside formulation details. Picking the wrong laminate can mean extra stability batches, slower registration and a product that fails before its printed expiry. Engineers need a working knowledge of how each film layer contributes to the moisture barrier, how it behaves on a thermoforming line, and where the cost-versus-protection trade-off sits.
Why moisture barrier selection matters in blister packaging
Water vapour transmission is the single most important packaging property for many active ingredients. Aspirin hydrolyses into salicylic and acetic acids, ranitidine degrades into nitrosamines, and probiotic capsules lose viability once internal moisture climbs past critical thresholds. Capsules that look dry can lose ten percent or more of their label claim over a year if the surrounding film offers no real barrier. Blister formats defend the dose through a two-sided approach: a thermoformed base web and a push-through lidding.
The base web is where PVC has historically done the heavy lifting, because it is inexpensive, transparent and easy to form at moderate temperatures. Plain 250-micron PVC, however, offers a moisture vapour transmission rate of 2.5 to 3.5 grams per square metre per day, acceptable for humidity-robust tablets but inadequate for sensitive molecules. The barrier has to be engineered through coatings and laminations, which is where ACLAR typically enters. Deciding whether to upgrade, and how far, is the heart of the film-selection problem.
Material properties of PVC and ACLAR films
PVC is a thermoplastic that softens predictably around 110 to 130 degrees Celsius, which makes it friendly to standard thermoforming stations on machines like those built by Huale. It accepts printing, accepts PVdC lacquers, and produces a clean cavity that machines can cut and code without brittleness. Its drawbacks are predictable: a poor moisture barrier and essentially no oxygen protection. Where neither matters, plain PVC remains the most economical answer and dominates over-the-counter formats sold through Australian retail chains.
ACLAR is a fluoropolymer film, chemically a polychlorotrifluoroethylene, marketed for decades under the Honeywell trade name. It is clear, tough and chemically inert, and carries a moisture barrier orders of magnitude better than PVC. A 23-micron ACLAR laminate can drop water vapour transmission to roughly 0.3 grams per square metre per day, and 51-micron grades reach below 0.1. The trade-off is cost, stiffness and forming behaviour, and ACLAR does not stretch like PVC. It is almost always bonded to a PVC or polyethylene carrier and formed as a laminate, behaving like PVC on the machine but performing like a high-barrier foil in the finished blister.
Common ACLAR gauge options and their protective thresholds
ACLAR laminates are commercially available in several gauges, and the rule of thumb is simple: thicker laminate, lower transmission, higher price. 7.5-micron films offer roughly a ten-fold improvement over plain PVC and suit mildly sensitive products that need a longer shelf life than uncoated PVC delivers. 15 and 23-micron grades are workhorses for genuinely moisture-sensitive molecules such as effervescent tablets, hormonal doses and selected antibiotics. 38 and 51-micron films sit at the top of the range, used where the cost of a failed stability study far outweighs the cost of the laminate.
Gauge selection should be driven by measured water vapour transmission rather than marketing language. A sponsor in Brisbane running accelerated stability at 40 degrees Celsius and 75 percent relative humidity needs to know the actual grams per square metre per day figure, not the supplier's general descriptor. Linking laminate choice to the dosage form's published critical relative humidity is more reliable. Hygroscopic APIs generally need barrier films below 0.5 grams per square metre per day, while moderately sensitive formulations can tolerate films in the 0.5 to 1.5 range if other packaging protections are layered in.
Matching laminations to product sensitivity profiles
A practical way to approach the decision is to rank the dosage form by sensitivity and assign a minimum film specification. For non-sensitive vitamins and mineral supplements sold through Australian warehouse clubs, plain PVC or PVC coated with a light PVdC lacquer is often sufficient. For moderately sensitive generics, including many antihypertensives and antihistamines, PVC laminated with 15 or 23-micron ACLAR is a sensible baseline. For highly sensitive or hygroscopic actives such as hormones, bisphosphonates and selected oncology doses, 38 or 51-micron ACLAR is the conservative choice and often what global stability guidelines expect.
The same logic applies to combination products, such as capsules co-packed with desiccant canisters, where the blister does not bear the full barrier burden. A product-development team in Adelaide evaluating a new ranitidine-equivalent can pair a mid-gauge ACLAR blister with a desiccant-containing push-through lid and meet shelf-life targets without the thickest, most expensive laminate. The art is to match the barrier to the molecule and validate the whole pack rather than each component in isolation. Many engineers find it useful to consult a capsule weight variation reference when capsule fills interact with blister headspace, because fill density and residual moisture both feed into the same shelf-life calculation.
Compatibility with blister forming and sealing equipment
The chemistry of the film is only half the problem; the mechanics of the line matter just as much. ACLAR laminates carry a different thermal mass than plain PVC, and need tighter control of forming temperature, plug-assist geometry and dwell time. Machines set up for 250-micron PVC will not automatically produce a clean cavity in a 250/23 PVC/ACLAR laminate, and trial runs on small batches are essential before any commercial commitment. Forming stations using infrared pre-heat and servo-controlled plug movement handle the laminate with less tuning, and modern Huale thermoforming lines are designed for higher-barrier webs.
Lidding choice also shifts when ACLAR is in play. A push-through aluminium foil of 20 to 25 microns is standard, but heat-seal lacquers should be matched to the laminate chemistry rather than carried over from a PVC-only pack. Peelable or child-resistant lid specifications for the Australian market, particularly for products dispensed under the PBS, often need a different sealing window than industrial bulk packs. Engineers looking to align their blister line with future serialisation and track-and-trace obligations will find practical guidance in resources on overwrapping upgrades for serialisation, increasingly relevant as the TGA tightens its expectations for tamper evidence.
Regulatory, supply and cost considerations for Australian manufacturers
Australian sponsors must demonstrate that the chosen container closure system supports the proposed shelf life, and that demonstration hinges on real-time or properly bracketed accelerated stability data. The TGA generally follows ICH guidelines for climatic zone conditioning, and Australia sits in zone II with a long-term reference of 25 degrees Celsius and 60 percent relative humidity, accelerated at 40 over 75. A laminate that performs well in those conditions but fails under the more punishing 30 over 65 tropical storage is a real risk for products distributed into northern Queensland or exported to South-East Asia. Some sponsors therefore over-specify the barrier to give themselves headroom across multiple storage scenarios.
Supply continuity is a second concern. ACLAR is produced in a limited number of qualified facilities, and lead time for high-gauge grades can stretch if a global brand order occupies capacity. Sponsors registering an ARTG entry that names a specific ACLAR gauge should hold a second-source qualification ready. Local distributors around Sydney and Melbourne stock 15 and 23-micron grades, but 38 and 51-micron laminates are usually indent orders. Documentation must be kept current, because the TGA's review of manufacturing site changes can revisit the original stability justification. Those evaluating the financial side of capital equipment decisions can review a conveying and crushing economics case study, where similar thinking about specification, throughput and long-term running cost applies.
The cost-versus-protection question deserves a closer look. The comparison below sets out the most common configurations encountered in Australian contract-packaging facilities, with indicative moisture vapour transmission rates and typical applications.
| Film configuration | Approximate MVTR (g/m²/day) | Relative cost index | Typical use in Australia |
|---|---|---|---|
| 250 µm PVC, uncoated | 2.5 to 3.5 | 1.0 | Non-sensitive vitamins, mineral supplements |
| 250 µm PVC with 60 gsm PVdC | 0.6 to 1.0 | 1.6 | Moderate-barrier generics, OTC analgesics |
| 250 µm PVC laminated with 15 µm ACLAR | 0.5 to 0.8 | 2.4 | Mildly sensitive tablets, effervescents |
| 250 µm PVC laminated with 23 µm ACLAR | 0.25 to 0.4 | 2.9 | Hormones, selected antibiotics, bisphosphonates |
| 250 µm PVC laminated with 38 µm ACLAR | 0.10 to 0.20 | 3.6 | Highly sensitive molecules, premium hospital packs |
| 250 µm PVC laminated with 51 µm ACLAR | below 0.10 | 4.3 | Critical-care and export-grade stability claims |
The cost index is a useful starting point but understates the financial picture. A laminate costing three times as much per square metre is often offset by a longer allowable shelf life, reducing the volume of returned stock and out-of-date write-offs that pharmacies and wholesalers absorb each year. For PBS-listed products, a six-month extension of shelf life can translate into meaningful reduction in annual supply-chain waste across the national distribution network. Over-engineering a barrier for a robust molecule simply adds cost without a stability return, a misallocation finance and operations teams quickly learn to flag.
Practical guidance for choosing a combination
When the formulation team hands a new molecule to packaging engineers, a short list of questions usually decides the laminate in a single meeting. Engineers across Adelaide, Brisbane and the larger Sydney contract-packaging houses tend to follow a similar path.
Questions that drive laminate selection
- What is the dosage form's critical relative humidity, and what is the residual moisture of the bulk after drying?
- What is the target shelf life, and which climatic zones will the finished product be stored and transported through?
- Does the existing forming line handle ACLAR laminates, and is the heat-seal lacquer on the lidding foil compatible with the laminate chemistry?
- Are there regulatory expectations, from the TGA or from export markets, that already dictate a minimum barrier specification?
If the answers point to a moderately sensitive API with a 24-month shelf life and standard Australian distribution, a 23-micron ACLAR laminate on 250-micron PVC is usually the right starting point. If the molecule is highly hygroscopic, or the product will be exported to hot and humid regions, 38 or 51-micron is worth the premium. If the molecule is genuinely insensitive, a PVdC-coated PVC is the most cost-effective option that still meets typical PBS dispensing expectations.
Common pairings for Australian conditions
- PVC 250 µm with 60 gsm PVdC for OTC analgesics and standard generics sold through community pharmacies.
- PVC 250 µm laminated with 23 µm ACLAR for hormonal products and bisphosphonates requiring 24 to 36 months of shelf life.
- PVC 250 µm laminated with 38 µm ACLAR for products distributed to tropical northern Queensland or exported to South-East Asia.
- PVC 250 µm laminated with 51 µm ACLAR for critical-care and oncology doses where any moisture ingress is unacceptable.
The decision is rarely between just two films; it is a calibrated climb from cheap to premium, anchored by what the molecule actually needs and what the regulatory dossier demands. Treating the laminate as an integral part of the formulation is what separates a stable commercial product from one that quietly fails its first stability pull.